Last €77.32 EUR
Change Today -1.15 / -1.47%
Volume 12.0K
BIM On Other Exchanges
Symbol
Exchange
BIM is not on other exchanges.
As of 11:15 AM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Alain Mérieux

Director, Transgene SA
AgeTotal Calculated CompensationThis person is connected to 76 board members in 6 different organizations across 9 different industries.

See Board Relationships
76--

Background*

Dr. Alain Mérieux founded bioMérieux SA. Dr. Mérieux serves as the Chief Executive Officer of Nouvelle bioMérieux Alliance. Dr. Mérieux serves as President of Institut Merieux, a holding company of bioMérieux SA. He serves as a Manager of SCI, ACCRA. He founded BD Mérieux in 1963. He served as the Chief Executive Officer and President at bioMérieux SA from 1965 to December 31, 2010. Dr. Mérieux served as the President and Chief Executive Officer of Institut Mérieux since ...

Read Full Background

Corporate Headquarters*

376, chemin de l’Orme
Marcy l'Etoile, Rhône-Alpes 69280

France

Phone: 33 4 78 87 20 00
Fax: 33 4 78 87 20 90

Board Members Memberships*

Former Director and Member of Audit Committee
Trustee
Chairman of The Board
1986-Present
Founder, Director, Chairman of Human Resources, Nominations & Compensation Committee and Chairman of Strategy Committee
1986-Present
Director and Chairman of Human Resources Committee
1993-Present
Director
2002-N/A
Former Director and Member of Audit Committee
2006-N/A
Former Director
2007-Present
Director

Education*

Unknown/Other Education 1968
Harvard Business School
Bachelor's Degree
Université Claude Bernard - Université Lyon I

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIM:FP €77.32 EUR -1.15

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
J. Joseph Kim Ph.D.Chief Executive Officer, President, Director and Member of Finance Committee
Inovio Pharmaceuticals, Inc.
$852.8K
Steven W. King Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc
Peregrine Pharmaceuticals, Inc.
$445.8K
Stanley C. Erck Chief Executive Officer, President, Director and Member of Finance Committee
Novavax, Inc.
$448.3K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
$533.3K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOMERIEUX, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.